ELIZABETH WILLIAMS

Profile

First Name

: ELIZABETH

Middle Name

:

Last Name

: WILLIAMS

Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
LOVE NEVER DIES LONDON L.P.
EXECUTIVE OFFICER
IMMUCELL CORP /DE/
MICHAEL F BRIGHAM, BOBBI BROCKMANN, JOSEPH CRABB, DAVID CUNNINGHAM, LINDA RHODES, JONATHAN ROTHSCHILD, DAVID TOMSCHE, PAUL WAINMAN
EXECUTIVE OFFICER, DIRECTOR
DATE ME OFF BROADWAY LTD LIABILITY CO
DIANE ALEXANDER
EXECUTIVE OFFICER
MEDICENNA THERAPEUTICS CORP.
ALBERT BERALDO, ALBERT G. BERALDO, KAREN DAWES, JOHN GELTOSKY, ANGELOS GEORGAKIS, DAVID HYMAN, NAGEATTE IBRAHIM, KARIM LALJI, FAHAR MERCHANT, ROSEMINA MERCHANT, CHANDRA PANCHAL, JOHN SAMPSON, ANDREW STRONG, RICHARD SUTIN
DIRECTOR
TRIUMVIRA IMMUNOLOGICS INC.
BRIAN M. BLOOM, CYNTHIA COLLINS, MBA, LEE COOPER, JURGEN ECKHARDT, SHAAN C. GANDHI, MD, DPHIL, JON IRVIN, DANIEL JANSE, PAUL LAMMERS, MD, MSC, TERESA MCROBERTS, WIDYA MULYASASMITA, SCOTT SMITH, ELIZABETH C. WILLIAMS
DIRECTOR
INNVENTURE, INC.
MICHAEL AMALFITANO, ROLAND AUSTRUP, AARON BERG, BRUCE BROWN, DEVERY (RUSTY) CAGLE, SAL CRAIG COGNETTI, JAMES DONNALLY, JAMES O. DONNALLY, JACK GRELLA, GREGORY HASKELL, GREGORY W. HASKELL, GREGORY WILLIAM HASKELL, DANIEL HENNESSY, DANIEL J. HENNESSY, SUZANNE NIEMEYER, MICHAEL OTWORTH, JOHN SCOTT, ELIAS GABRIEL SILVERMAN, DAVID YABLUNOSKY
EXECUTIVE OFFICER
SATELLOS BIOSCIENCE INC.
RIMA AL-AWAR, RICHARD BARKER, FRANKLIN BERGER, BRIAN BLOOM, STEPHANIE BROWN, JOHN CLEMENT, MICHAEL ROBERT CROSS, FRANK GLEESON, J. ROBERT HALL, NOEL HALL, PETER HNIK, DOUGLAS G. JANZEN, BILL JAROSZ, WILLIAM JAROSZ, SUSAN KOPPY, PHILIP D. LAMBERT, MICHAEL LIGGETT, GEOFF MACKAY, WILLIAM MCVICAR, W JOHN MEEKISON, W. JOHN MEEKISON, ADAM MOSTAFA, SANTA JEREMY ONO, ANDREW RAE, ANDREW J. RAE, MICHAEL RUDNICKI, COURTNEY WELLS, WARREN WHITEHEAD
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-10-10
D
Link
OTHER TECHNOLOGY 
BLANK CHECKS [6770] 
DECLINE TO DISCLOSE 
Equity 
2025-10-03 
2025-04-08
D
Link
BUSINESS SERVICES 
BLANK CHECKS [6770] 
DECLINE TO DISCLOSE 
Equity 
2025-03-24 
2025-01-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-12-20 
2024-10-16
D
Link
BUSINESS SERVICES 
BLANK CHECKS [6770] 
DECLINE TO DISCLOSE 
Equity 
2024-10-01 
2021-05-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-04-26 
2020-04-20
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-03-17 
2020-03-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-03-17 
2019-09-17
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
 
2019-04-03 
2016-10-24
D
Link
PHARMACEUTICALS 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
$5,000,001 - $25,000,000 
Equity 
2016-10-21 
2010-02-09
D/A
Link
OTHER 
 
$1 - $1,000,000 
 
2009-10-23